Evidence map›Paper›PMID 41366717›Full record

ArticleJournal of health, population, and nutrition2025

A comparative assessment of data completeness of the adverse events following immunization (AEFI) in DHIS2 at the early implementation stage in Bangladesh.

Afroza Akter, Imam Tauheed, Md Golam Firoj, Sabina Shahnaz, Md Shahinur Rahaman, Md Tanvir Hossen, Firdausi Qadri, Fahima Chowdhury

Abstract readComparative Study
In one paragraph

Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Afroza AkterInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh.
Imam TauheedInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh.
Md Golam FirojInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh.
Sabina ShahnazInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh.
Md Shahinur RahamanInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh.
Md Tanvir HossenEPI, Directorate General of Health Services, Dhaka, Bangladesh.
Firdausi QadriInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh.
Fahima ChowdhuryInfectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Mohakhali, 1212, Dhaka, Bangladesh. fchowdhury@icddrb.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData completeness is crucial in making evidence-based decisions in low- and middle-income countries (LMICs). A total of 130 countries have adopted the District Health Information System (DHIS2) platform in the health sector to generate good-quality data. In 2021, Bangladesh implemented DHIS2 as a platform for monitoring and surveillance of adverse events following immunization (AEFI). This study aimed to assess the level of completeness of AEFI data reported in DHIS2 during the early implementation phase through existing AEFI surveillance systems in Bangladesh.

methodsWe conducted a facility-based cross-sectional study. Based on a desk review of the 2023 AEFI data, we selected three divisions (Chattogram, Sylhet, and Rangpur) of Bangladesh based on high-, medium-, and low-performing groups according to the AEFI reporting rate. A total of 97 AEFI cases were found in the DHIS2 system for the assessment from six selected health facilities, which were reported between January and December 2023. The AEFI reporting form contains 50 variables to be completed by health assistants on paper-based forms (established method), and the DHIS2 tracker contains the identical variable set as a paper-based AEFI form. A comparative analysis was conducted between these two data sources, field by field, with the number count and percentages using McNemar's test.

resultsNinety-five paper-based AEFI reporting forms were found to be consistent with the DHIS2 AEFI tracker system (two hard copies were misplaced in two sites), and these matched AEFI cases were assessed for overall data completeness in the paper-based forms and the DHIS2 system. We found that 75.04% of the variable entries were available in paper-based forms, whereas 67.87% were available in the DHIS2 system (p < 0.001). The name of the patient, date of birth, AEFI (signs and symptoms), and date of AEFI onset were documented appropriately in the paper-based AEFI and the DHIS2 Tracker. Other variables were found to be either overreported or underreported in the DHIS2.

conclusionAt this early stage of the DHIS2 implementation, the data completeness of mandatory field entries was moderate. We recommend periodic supportive supervision by health management teams, including regular data feedback to improve completeness.

Indexed as

Adverse Drug Reaction Reporting SystemsData AccuracyHealth Information SystemsImmunizationBangladeshCross-Sectional StudiesHumansImmunization ProgramsAEFIBangladeshData completenessDHIS 2

Identifiers

PMID41366717
PMCPMC12801796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.